日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global genomic population structure of wild and cultivated oat reveals signatures of chromosome rearrangements

野生和栽培燕麦的全球基因组群体结构揭示了染色体重排的特征

Bekele, Wubishet A; Avni, Raz; Birkett, Clayton L; Itaya, Asuka; Wight, Charlene P; Bellavance, Justin; Brodführer, Sophie; Canales, Francisco J; Carlson, Craig H; Fiebig, Anne; Li, Yongle; Michel, Steve; Nandety, Raja Sekhar; Waring, David J; Arbelaez, Juan D; Beattie, Aaron D; Caffe, Melanie; Del Blanco, Isabel A; Fiedler, Jason D; Gupta, Rajeev; Gutierrez, Lucia; Harris, John C; Harrison, Stephen A; Herrmann, Matthias H; Huang, Yung-Fen; Isidro Y Sanchez, Julio; McMullen, Michael S; Mitchell Fetch, Jennifer W; Nilsen, Kirby T; Parkin, Isobel A P; Peng, YuanYing; Smith, Kevin P; Sutton, Tim; Yan, Weikai; Zwer, Pamela; Diederichsen, Axel; Esvelt Klos, Kathy; Fu, Yong-Bi; Howarth, Catherine J; Jannink, Jean-Luc; Jellen, Eric N; Langdon, Tim; Maughan, Peter J; Paczos-Grzeda, Edyta; Prats, Elena; Sen, Taner Z; Mascher, Martin; Tinker, Nicholas A

Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer

吉西他滨与卡培他滨为基础的放化疗治疗胰腺癌的随机 2 期试验的循环生物标志物和结果

Frances Willenbrock, Catrin M Cox, Eileen E Parkes, Charlotte S Wilhelm-Benartzi, Aswin G Abraham, Robert Owens, Ahmad Sabbagh, Christopher M Jones, Daniel L I Hughes, Tim Maughan, Christopher N Hurt #, Eric E O'Neill #, Somnath Mukherjee #

Preclinical testing of an Atr inhibitor demonstrates improved response to standard therapies for esophageal cancer

Atr 抑制剂的临床前测试表明,食管癌对标准疗法的反应有所改善

Katarzyna B Leszczynska, Greg Dobrynin, Rhea E Leslie, Jonathan Ient, Adam J Boumelha, Joana M Senra, Maria A Hawkins, Tim Maughan, Somnath Mukherjee, Ester M Hammond